Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

186.96+1.29 (+0.69%)

As of 11:48AM EDT. Market open.

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Neutralpattern detected

All

Zacks
Verrica (VRCA) Gets CRL From the FDA for Skin Disease Drug
Verrica (VRCA) suffers a setback yet again as the FDA issues a CRL for its lead product candidate VP-102. Consequently, shares are trading down.
- Verrica Pharma Shares Slide After Response Letter From FDA
  Benzinga
- Verrica Pharmaceuticals Receives Complete Response Letter from the FDA identifying deficiencies at a facility of a Contract Manufacturer for its New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
  GlobeNewswire
Motley Fool
Is Now the Time to Ditch Pharma Stocks?
With drug pricing reform on the horizon, investors may want to analyze their allocation.
Motley Fool
3 Winning Stocks Down 33% (or More) to Buy Hand Over Fist
For nearly 18 months, investors have enjoyed a historic bounce-back rally in the stock market. The following trio of stocks are all down at least 33%, if not more, from their 52-week highs, but can be confidently bought hand over fist by investors. The first winning stock that's been beaten down of late is technology-driven real estate company Redfin (NASDAQ: RDFN).
- You're Just in Time to Buy This Value Stock
  Motley Fool
- 3 Growth Stocks to Buy Hand Over Fist Right Now
  Motley Fool